Video Experimental Relacionado
Updated: May 21, 2026
05:10
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Las nuevas mutaciones se dirigen a distintos subgrupos de medulloblastoma
Giles Robinson1, Matthew Parker, Tanya A Kranenburg
1St Jude Children's Research Hospital, Washington University Pediatric Cancer Genome Project, Memphis, Tennessee 38105, USA.
Nature
|June 23, 2012
Resumen
Este estudio identificó nuevas mutaciones genéticas que impulsan el meduloblastoma, un tumor cerebral infantil. Estos hallazgos revelan distintas alteraciones epigenéticas en diferentes subgrupos de medulloblastoma, ofreciendo posibles objetivos terapéuticos.
Área de la Ciencia:
- La genómica es la genómica.
- Oncología Oncología.
- Biología Molecular Biología Molecular
Sus antecedentes:
- El meduloblastoma es un tumor cerebral infantil maligno con cuatro subgrupos moleculares distintos.
- Comprender los factores genéticos del meduloblastoma es crucial para desarrollar terapias dirigidas.
Objetivo del estudio:
- Identificar nuevas mutaciones somáticas que impulsan el desarrollo del medulloblastoma en todos sus subgrupos.
- Investigar el papel de las alteraciones de la maquinaria epigenética en la patogénesis del medulloblastoma.
Principales métodos:
- Secuenciación del genoma completo de 37 tumores de meduloblastoma y sangre normal coincidente.
- Secuenciación dirigida de 136 genes en otros 56 medulloblastomas.
- Modelado in vivo de mutaciones en progenitores de ratón para el meduloblastoma del subgrupo WNT.
Principales resultados:
- Identificó mutaciones recurrentes en 41 genes no caracterizados previamente.
- Se descubrieron alteraciones epigenéticas específicas del subgrupo, incluidos los reguladores de la trimetilación H3K27 y H3K4 (por ejemplo, KDM6A, ZMYM3) en los subgrupos 3 y 4.
- Se encontraron remodeladores de cromatina asociados a CTNNB1 (por ejemplo, SMARCA4, CREBBP) en tumores del subgrupo WNT.
- Los modelos de ratón revelaron genes que mantienen el linaje celular (DDX3X) e inician / cooperan en la tumorigénesis (CDH1, PIK3CA).
Conclusiones:
- Este estudio proporciona información significativa sobre la patogénesis molecular de los subgrupos de medulloblastoma.
- Se identificaron nuevos impulsores genéticos y objetivos terapéuticos para el meduloblastoma, con especial atención a los reguladores epigenéticos.
Videos de Conceptos Relacionados
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...